Defining the mutational profile of lower-risk myelodysplastic neoplasm patients with respect to disease progression using next-generation sequencing and pyrosequencingMonika Adamska, Lidia Gil, Joanna Czerwińska-Rybak et al.|Współczesna Onkologia|2023Cited by 0